Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Chengdu Kanghong Pharmaceutical Group Co., Ltd., commonly referred to as Kanghong, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Chengdu, China. Established in 1998, the company has made significant strides in developing innovative pharmaceutical products, particularly in the fields of ophthalmology and oncology.
Kanghong's core offerings include a range of high-quality injectable medications and advanced drug delivery systems, distinguished by their efficacy and safety profiles. With a strong commitment to research and development, the company has achieved notable milestones, including several national and international certifications.
Recognised for its robust market position, Chengdu Kanghong Pharmaceutical Group has expanded its operational reach across various regions, contributing to its reputation as a trusted name in the pharmaceutical sector.
-19 vs industry average
Chengdu Kanghong Pharmaceutical Group Co., Ltd’s score of 23 is lower than 26% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Chengdu Kanghong Pharmaceutical Group Co., Ltd yet.
Chengdu Kanghong Pharmaceutical Group Co., Ltd, a pharmaceutical preparation manufacturing company based in China, has not yet publicly disclosed specific figures for its carbon emissions. While no emissions data is available for reporting, the company is actively engaged in climate action and is committed to reducing its environmental impact.
As an organisation within the pharmaceutical sector, Chengdu Kanghong Pharmaceutical Group Co., Ltd operates within an industry that is increasingly focused on sustainability and climate stewardship. The pharmaceutical industry, by its nature, involves complex manufacturing processes, supply chains, and significant energy consumption, all of which contribute to its carbon footprint.
Despite the absence of explicit emissions figures, the company's commitment to climate action is evident. It is anticipated that Chengdu Kanghong Pharmaceutical Group Co., Ltd will align its operations with global climate goals and industry best practices. This will likely involve setting ambitious science-based targets for emissions reduction and implementing strategies to mitigate its environmental impact across its value chain. Further details on specific reduction initiatives and targets are expected to be released as the company progresses in its sustainability journey.
No climate goals have been disclosed for Chengdu Kanghong Pharmaceutical Group Co., Ltd yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more